We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Evolutec Grp | EVC | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
41.00 | 41.00 |
Top Posts |
---|
Posted at 22/1/2008 17:24 by colonel a Why don't EVC let somebody like LSB take them over ?It could be cheaper money than elsewhere and still offer a very good return to EVC holders. |
Posted at 09/9/2007 22:25 by rainmaker Thought a few People here might be interested in this Posting so copied from the Value Thread(VAL)I believe in Evolutec(EVC) you've most definitely hit the paydirt.Their is so much I like about this Company-for example unlike Evolutec,the vast majority of Cash shells I have come across trade at a premium and not discount to their cash balance.Evolutec has £6.2mln cash v £4.5mln market cap. I estimate that if you bought now and they voluntarily liquidated in a year's time which they will be forced to by the newish AIM rules re Cash Shells(introduced in April 2007) then you will make approx 38% but if there is a reverse takeover then sky's the limit-I've seen cash shells like this multiply their share price five even 10 fold in a very short space of time . This reminds me of Ben Graham's old adage that a good investment is a good speculation, in that if a company's share price has limited downside then conversely it must offer good upside potential! It's no surpise to me that their major Institutional Shareholder, Gartmore opposed and subsequently blocked, a voluntary liquidation. Look also at the Company's tax losses-in the last four years they have lost approximately £20mln and think what that is worth to an acquiring Company seeking a listing. Also consider the time and expense a Company spends preparing for a listing. I've heard figures of 9 months and £250k.Basically I think this Company at current prices is a win, win situation. I would also be very surprised if they failed to attract a Suitor. regards |
Posted at 09/5/2007 10:23 by hugepants These things can drag on a while unfortunately. PIX took 5 months or so to announce a sale. Hopefully it wont be as long here. Ive got quite a lot of cash tied up in EVC now.Another couple that may be worth looking at are BEK with share price of 5.75p and cash and bonds worth 16p, and Asterand (ATD) which is another biotech, market cap £5M and cash of £4M. |
Posted at 16/4/2007 12:12 by pugg1ey This is probably me being a reallly naive PI but I have just added another 15K at 18.2p. I am getting quotes to sell 50K which is unheard of regarding EVC in my lifetime! Perhaps a deal is near and someone wants stock? (or probably I'll get shafted with a load of illiquid shares!) he who dares wins! |
Posted at 13/3/2007 17:01 by frank spencer The downside, with or without a takeover, seems to have very limited downside at current levels imo.Without a takeover, the company would be forced to fold up by the shareholders, who would receive, after break up costs, something like 20-22p per share imo. With a takeover, a fair bit more. The price action is currently because the company is too small too attract the larger funds now, and KBC are obviously reducing their books generally, as opposed to anything being EVC specific. The vast majority of other shareholders are just waiting for further developments, which are unlikely to be disappointing given the new broker, and the fact that the directors really cannot let down shareholders yet again. imo. |
Posted at 11/3/2007 18:58 by sruk77 Early stages in the takeover bid and the price goes up 9% - under what condition is EVC recommended as a sell by some brokers? The speculation alone will drive the share price 25 within the next fortnight. |
Posted at 10/3/2007 11:17 by sruk77 EVC recieved several proposals and also a return of cash to shareholders; Now the fun begins, and a nice hefty profit for those of us that hold at these levels.I have not come across a company in this position before. I really hate companies that have no idea what strategic direction they are moving in (my biggest gripe about UNG). This is not the sort of recovery play I go for. But I will watch with interest from the side lines to see what happens. I am particularly intrigued to see what value the work on tick saliva yields. rEV576 has passed stage one and two - unlike rEV131 which failed stage one and was shelved. Good will hunting to those who hold it as I make my decision to buy on Monday. |
Posted at 09/3/2007 14:57 by jonfa yes it is, even if it is evc. |
Posted at 09/3/2007 14:56 by dubbsie This is EVC!! |
Posted at 09/3/2007 14:23 by initiate Is this the same EVC that Jeremy Batstone was ramping on TV at 180p ? Sorry for that slip - corrected now. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions